These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 24520210)

  • 1. γδ T cells and their potential for immunotherapy.
    Wu YL; Ding YP; Tanaka Y; Shen LW; Wei CH; Minato N; Zhang W
    Int J Biol Sci; 2014; 10(2):119-35. PubMed ID: 24520210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia.
    Sawaisorn P; Tangchaikeeree T; Chan-On W; Leepiyasakulchai C; Udomsangpetch R; Hongeng S; Jangpatarapongsa K
    Immunol Invest; 2019 Jan; 48(1):11-26. PubMed ID: 30321079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
    Gougeon ML; Malkovsky M; Casetti R; Agrati C; Poccia F
    Vaccine; 2002 May; 20(15):1938-41. PubMed ID: 11983250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
    Correia DV; d'Orey F; Cardoso BA; Lança T; Grosso AR; deBarros A; Martins LR; Barata JT; Silva-Santos B
    PLoS One; 2009 May; 4(5):e5657. PubMed ID: 19479075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γδ T-APCs: a novel tool for immunotherapy?
    Moser B; Eberl M
    Cell Mol Life Sci; 2011 Jul; 68(14):2443-52. PubMed ID: 21573785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of human peripheral blood γδ T cells using zoledronate.
    Kondo M; Izumi T; Fujieda N; Kondo A; Morishita T; Matsushita H; Kakimi K
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21931292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity antigens for human gammadelta T cells.
    Sarikonda G; Wang H; Puan KJ; Liu XH; Lee HK; Song Y; Distefano MD; Oldfield E; Prestwich GD; Morita CT
    J Immunol; 2008 Dec; 181(11):7738-50. PubMed ID: 19017963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γδ T-cell immunotherapy for lung cancer.
    Yoshida Y; Nakajima J; Wada H; Kakimi K
    Surg Today; 2011 May; 41(5):606-11. PubMed ID: 21533930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA.
    Xu B; Pizarro JC; Holmes MA; McBeth C; Groh V; Spies T; Strong RK
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2414-9. PubMed ID: 21262824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-lymphoma effect of gammadelta T cells.
    Kunzmann V; Wilhelm M
    Leuk Lymphoma; 2005 May; 46(5):671-80. PubMed ID: 16019504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
    Liu Z; Guo B; Lopez RD
    J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens.
    Kato Y; Tanaka Y; Miyagawa F; Yamashita S; Minato N
    J Immunol; 2001 Nov; 167(9):5092-8. PubMed ID: 11673519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes.
    Poccia F; Gougeon ML; Agrati C; Montesano C; Martini F; Pauza CD; Fisch P; Wallace M; Malkovsky M
    Curr Mol Med; 2002 Dec; 2(8):769-81. PubMed ID: 12462396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γδ T cell receptor ligands and modes of antigen recognition.
    Champagne E
    Arch Immunol Ther Exp (Warsz); 2011 Apr; 59(2):117-37. PubMed ID: 21298486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.